On this page

Nasal Allergy

Triamcinolone acetonide · Spray, Metered

Over-the-counter ANDA Official labelling
Informational index, not medical advice. Content is reproduced from public FDA and NLM data. Always confirm against the manufacturer's current prescribing information. Report adverse events to FDA MedWatch.

Overview

Brand name
Nasal Allergy
Generic name
Triamcinolone acetonide
Dosage form
Spray, Metered
Route
Nasal
Marketing category
ANDA · ANDA
Labeler
H E B
Product type
Human Otc Drug
DEA schedule
Not scheduled
Active ingredients
1
NDC product codes
6
Packages
9
Data completeness
82% of corroborating sources present

Active ingredients

Source: NDC Directory
Active ingredients and strengths as listed in the NDC Directory.
Ingredient Strength RxCUI Monograph
Triamcinolone Acetonide 55 ug/1 1014314 View

Forms, strengths and routes

Source: NDC Directory
Dosage form
Spray, Metered
Route of administration
Nasal
Presentations
15

Pharmacologic classes are listed in the class section below.

Pharmacologic class

Source: NDC Directory
Established pharmacologic classes (EPC), mechanisms of action (MoA), chemical structures (CS) and physiologic effects (PE).
Class Type Browse
Corticosteroid Hormone Receptor Agonists [MoA] MoA All 215 members
Corticosteroid [EPC] EPC All 215 members

Regulatory status

Source: Drugs@FDANDC Directory
Application number
078104
Application type
ANDA · Abbreviated New Drug Application
Approval date
July 30, 2009
Sponsor
PERRIGO PHARMA INTL
Products on application
2
Submissions recorded
6
Products approved under application 078104.
Product Trade name Form Strength Ingredient Status TE Flags
078104-001 TRIAMCINOLONE ACETONIDE SPRAY, METERED TRIAMCINOLONE ACETONIDE Discontinued —
078104-002 TRIAMCINOLONE ACETONIDE SPRAY, METERED TRIAMCINOLONE ACETONIDE Over-the-counter —

Approval history

Source: Drugs@FDA
Most recent submissions on application 078104.
Type No. Action Status Date Review
Supplement 17 Labeling Approved November 12, 2020 Standard
Supplement 11 Labeling Approved November 12, 2020 Standard
Supplement 6 Labeling Approved November 12, 2020 Standard
Supplement 7 Manufacturing (CMC) Approved May 25, 2018 —
Supplement 3 Labeling Approved November 14, 2014 Standard
Original application 1 Approved July 30, 2009 —

Review documents

  • 0 · Original application · August 6, 2009
  • 0 · Original application · July 30, 2009

Prescribing information

Source: openFDA Drug Labeling

Reproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20260805). This is the manufacturer's labelling text, not a summary and not advice.

HUMAN OTC DRUG · 20260805 HUMAN OTC DRUG · 20260521 HUMAN OTC DRUG · 20241127

Indications and Usage

openFDA Drug Labeling

Uses temporarily relieves these symptoms of hay fever or other upper respiratory allergies: • nasal congestion • runny nose • sneezing • itchy nose

Purpose Allergy symptom reliever

Dosage and Administration

openFDA Drug Labeling

Directions Read insert (inside package) on how to: • get a new bottle ready (primed) before first use • prime bottle again if not used for more than 2 weeks • use the spray • clean the spray nozzle ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER adults and children 12 years of age and older • once daily, spray 2 times into each nostril while sniffing gently • once your allergy symptoms improve, reduce to 1 spray in each nostril per day CHILDREN 2 TO UNDER 12 YEARS OF AGE • the growth rate of some children may be slower while using this product. Talk to your child’s doctor if your child needs to use the spray for longer than two months a year. children 6 to under 12 years of age • an adult should supervise use • once daily, spray 1 time into each nostril while sniffing gently • if allergy symptoms do not improve, increase to 2 sprays in each nostril per day. Once allergy symptoms improve, reduce to 1 spray in each nostril per day. children 2 to under 6 years of age • an adult should supervise use • once daily, spray 1 time into each nostril while sniffing gently children under 2 years of age • do not use • do not use more than directed • if you forget a dose, do not double the next dose • do not spray into eyes or mouth • if allergy symptoms do not improve after one week, stop using and talk to a doctor • do not use for the common cold • shake well before each use

Warnings Do not use • in children under 2 years of age • if you have ever had an allergic reaction to any of the ingredients Ask a doctor before use if you • have had recent nose ulcers or nose surgery • have had a nose injury that has not healed • are using a steroid medicine for asthma, allergies or skin rash • have an eye infection • have or had glaucoma or cataracts When using this product • the growth rate of some children may be slower • some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief. • do not share this bottle with anyone else as this may spread germs • remember to tell your doctor about all the medicines you take, including this one Stop use and ask a doctor if • you have, or come into contact with someone who has, chickenpox, measles or tuberculosis • you have or develop symptoms of an infection such as a persistent fever • you have any change in vision • you have severe or frequent nosebleeds If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Do not use • in children under 2 years of age • if you have ever had an allergic reaction to any of the ingredients

Ask a Doctor

openFDA Drug Labeling

When using this product the growth rate of some children may be slower some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief. do not share this bottle with anyone else as this may spread germs remember to tell your doctor about all the medicines you take, including this one

Stop use and ask a doctor if • you have, or come into contact with someone who has, chickenpox, measles or tuberculosis • you have or develop symptoms of an infection such as a persistent fever • you have any change in vision • you have severe or frequent nosebleeds

Active Ingredient

openFDA Drug Labeling

Active ingredient (in each spray) Triamcinolone acetonide 55 mcg (glucocorticoid)

Adverse event reports

Source: openFDA FAERS
31,697
FAERS reports mentioning this drug
as of 2026-09-25T03:42:24+00:00
A report count is not a risk measure. FAERS accepts voluntary and mandatory reports without establishing causation, and reporting is influenced by how widely a drug is used, how long it has been marketed, and media attention. FDA states that reports “do not prove that the drug caused the event”. Compare rates, not totals.

Attributed to this product's most-reported active ingredient: TRIAMCINOLONE ACETONIDE. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.

Packaging and NDCs

Source: NDC Directory
Every National Drug Code package associated with this medication. The NDC is the identifier used for dispensing, billing and pharmacovigilance in the United States.
Package NDC Product NDC Labeler Description Marketing start
59779-746-01 59779-746 CVS Pharmacy 1 BOTTLE, SPRAY in 1 CARTON (59779-746-01) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY April 10, 2016
59779-746-02 59779-746 CVS Pharmacy 1 BOTTLE, SPRAY in 1 CARTON (59779-746-02) / 60 SPRAY, METERED in 1 BOTTLE, SPRAY May 1, 2017
59779-746-03 59779-746 CVS Pharmacy 2 BOTTLE, SPRAY in 1 CARTON (59779-746-03) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY December 13, 2016
37808-443-01 37808-443 H E B 1 BOTTLE in 1 CARTON (37808-443-01) / 120 SPRAY, METERED in 1 BOTTLE March 30, 2017
42507-443-01 42507-443 HyVee Inc 1 BOTTLE, SPRAY in 1 CARTON (42507-443-01) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY (42507-443-00) December 30, 2016
30142-813-01 30142-813 Kroger Company 1 BOTTLE, SPRAY in 1 CARTON (30142-813-01) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY March 17, 2020
30142-813-03 30142-813 Kroger Company 2 BOTTLE, SPRAY in 1 CARTON (30142-813-03) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY March 9, 2021
0536-1457-69 0536-1457 Rugby Laboratories 1 BOTTLE, SPRAY in 1 CARTON (0536-1457-69) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY November 11, 2025
21130-613-02 21130-613 Safeway 1 BOTTLE, SPRAY in 1 CARTON (21130-613-02) / 60 SPRAY, METERED in 1 BOTTLE, SPRAY August 1, 2025
59779-746 59779-746 CVS Pharmacy — April 10, 2016
37808-443 37808-443 H E B — March 30, 2017
42507-443 42507-443 HyVee Inc — December 30, 2016
30142-813 30142-813 Kroger Company — March 17, 2020
0536-1457 0536-1457 Rugby Laboratories — November 11, 2025
21130-613 21130-613 Safeway — August 1, 2025

Sources for this page

Every dataset that contributed a fact to this page.
Dataset Agency Used for
NDC Directory FDA Identity, ingredients, strengths, forms, routes, labelers, packages
Drugs@FDA FDA Application, sponsor, submissions, review documents, marketing status
Drug Labeling FDA / NLM Prescribing information reproduced above
FAERS FDA Adverse event report counts

Generated September 25, 2026 · 10 sections on this page.